Treatment with high-dose cytostatic agents
Wisløff, F.; Brinch, L.; Bruserud, O.; Dahl, I.M.; Lamvik, J.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 114(26): 3115-3116
1994
ISSN/ISBN: 0029-2001 PMID: 7974435 Document Number: 432439
Document emailed within 1 workday
Related Documents
Husebekk, A.; Kolstad, A.; Dahl, I.M.; Skogen, B. 1998: Decentralized high-dose cytostatic treatment with autologous stem cell support Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(18): 2777-2780Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Verdonck, L.F.; Vendrik, C.P.; Dekker, A.W.; van Kempen, M.L.; Schornagel, J.H.; Rozenberg-Arska, M.; de Gast, G.C. 1985: High dose cytotoxic agents followed by autologous bone marrow transplantation; treatment results in 25 patients with various malignancies Nederlands Tijdschrift Voor Geneeskunde 129(25): 1186-1190
Capizzi, R.L.; Powell, B.L. 1987: Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias Seminars in Oncology 14(2 Suppl 1: 40-50
Steineck, G.; Wijkström, H.; Borghede, G. 1994: Treatment of bladder cancer with cytostatic agents Lakartidningen 91(5): 397-404
Rauh, J.; Pluntke, S.; Müller, C. 2004: Treatment of perivascular extravasation of cytostatic agents MMW Fortschritte der Medizin 146(31-32): 23-24; 26-27
Halvorsen, S. 1971: Cytostatic agents in treatment of the nephrotic syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 737
Chlund, K. 1970: Treatment of ulcerative colitis with cytostatic agents Wiener Medizinische Wochenschrift 120(16): 274
Ringborg, U. 1990: Identification of resistance factors is a step towards optimized treatment with cytostatic agents Lakartidningen 87(21): 1880-1882
Larsson, P.A. 1999: Treatment with cytostatic agents should be considered in colorectal cancer. it improves prognosis and quality of life Lakartidningen 96(19): 2314-2316
Nilsson, A.; Björk, O. 2001: A mannose-binding blood protein reduces the risk of infections drug treatment with cytostatic agents Lakartidningen 98(50): 5780
Davis, J.C.; Fessler, B.J.; Tassiulas, I.O.; McInnes, I.B.; Yarboro, C.H.; Pillemer, S.; Wilder, R.; Fleisher, T.A.; Klippel, J.H.; Boumpas, D.T. 1998: High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis Journal of Rheumatology 25(9): 1694-1704
Schneider, W.; Bussmann, W.D.; Stahl, B.; Wietschoreck, A.; Kaltenbach, M. 1985: The antianginal efficacy of isosorbide dinitrate: dose-response relation and long-term effects of high-dose treatment Zeitschrift für Kardiologie 74(Suppl 1): 55-63
Arlin, Z.A.; Feldman, E.J.; Finger, L.R.; Ahmed, T.; Mittelman, A.; Cook, P.; Puccio, C.; Baskind, P.; Arnold, P.; Razis, E.D. 1991: Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia Leukemia 5(8): 712-714
Röttinger, E.M. 1995: Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(5): 303-304
Fine, H.A.; Antman, K.H. 1992: High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience Bone Marrow Transplantation 10(4): 315-321
Schmidt, C.G. 1971: Alkylating cytostatic agents Der Internist 12(Suppl 1): 119-127
Schwab, W.; Ries, G.; Handschuh, K. 1986: Initial experiences with interstitial brachycurietherapy (low dose rate I-125 seeds in carrier/vicryl and high dose rate Ir-192 afterloading system) in the palliative treatment of head and neck tumors Hno 34(8): 327-333
Brieghel, A.; Bille, I.; Sørensen, C. 1991: Cytostatic agents. Pharmacists on the ward Sygeplejersken 91(37): 18-19; 26
Fernández-Hidalgo, O.A.; Vanaclocha, V.; Vieitez, J.M.; Aristu, J.J.; Rebollo, J.; Gúrpide, A.; Aramendía, J.M.; Moreno-Palanques, R.; Martín-Algarra, S.; Subirá, M.L.; Brugarolas, A. 1996: High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients Bone Marrow Transplantation 18(1): 143-149